The cGAS–STING pathway and cancer

N Samson, A Ablasser - Nature cancer, 2022 - nature.com
The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway has
emerged as a critical innate immune pathway that, following engagement by DNA, promotes …

Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

NK Wolf, DU Kissiov, DH Raulet - Nature Reviews Immunology, 2023 - nature.com
Great strides have been made in recent years towards understanding the roles of natural
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …

Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy

KM Garland, TL Sheehy, JT Wilson - Chemical reviews, 2022 - ACS Publications
The stimulator of interferon genes (STING) cellular signaling pathway is a promising target
for cancer immunotherapy. Activation of the intracellular STING protein triggers the …

Role of the cGAS–STING pathway in systemic and organ-specific diseases

S Skopelja-Gardner, J An, KB Elkon - Nature Reviews Nephrology, 2022 - nature.com
Cells are equipped with numerous sensors that recognize nucleic acids, which probably
evolved for defence against viruses. Once triggered, these sensors stimulate the production …

Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway

J Kim, HS Kim, JH Chung - Experimental & Molecular Medicine, 2023 - nature.com
In addition to constituting the genetic material of an organism, DNA is a tracer for the
recognition of foreign pathogens and a trigger of the innate immune system. cGAS functions …

Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles

P Dosta, AM Cryer, MZ Dion, T Shiraishi… - Nature …, 2023 - nature.com
Intravenously administered cyclic dinucleotides and other STING agonists are hampered by
low cellular uptake and poor circulatory half-life. Here we report the covalent conjugation of …

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

WSME Theelen, D Chen, V Verma… - The Lancet …, 2021 - thelancet.com
Background Radiotherapy might augment systemic antitumoral responses to
immunotherapy. In the PEMBRO-RT (phase 2) and MDACC (phase 1/2) trials, patients with …

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

M McLaughlin, EC Patin, M Pedersen, A Wilkins… - Nature Reviews …, 2020 - nature.com
The development of immune checkpoint inhibitors (ICIs) is revolutionizing the way we think
about cancer treatment. Even so, for most types of cancer, only a minority of patients …

The balance of STING signaling orchestrates immunity in cancer

KRB Lanng, EL Lauridsen, MR Jakobsen - Nature Immunology, 2024 - nature.com
Over the past decade, it has become clear that the stimulator of interferon genes (STING)
pathway is critical for a variety of immune responses. This endoplasmic reticulum-anchored …

Chromosomal instability as a driver of cancer progression

X Chen, AS Agustinus, J Li, M DiBona… - Nature Reviews …, 2024 - nature.com
Chromosomal instability (CIN) refers to an increased propensity of cells to acquire structural
and numerical chromosomal abnormalities during cell division, which contributes to tumour …